XML 63 R47.htm IDEA: XBRL DOCUMENT v3.25.0.1
Intangible Assets (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 12 Months Ended
Sep. 17, 2024
Oct. 31, 2023
Aug. 23, 2020
Feb. 28, 2023
Dec. 31, 2019
Dec. 31, 2024
Dec. 31, 2023
Jan. 07, 2020
Intangible Assets [Line Items]                
Direct ownership of equity         98.47%      
Percentage of voting equity interests acquired       100.00%       100.00%
Aggregate upfront payment (in Dollars)       $ 3,500        
Ordinary shares (in Shares) 200   200 110,759        
Long term milestones aggregate amount (in Dollars)       $ 94,000        
Total acquisition (in Dollars)       3,600        
Fair value of issued equity (in Shares)           110,759    
Fair value of issued intangible assets (in Dollars)           $ 3,781    
Aggregate shareholders of immunorizon (in Shares)   34,974            
Share price (in Dollars per share)           $ 1.59    
Description of expected volatility percentage           70.89%    
Description of expected annual risk free rate           4.50%    
Dividend yield            
Percentage of discount for lack of marketability           10.80%    
Intangible assets recoverable amount percentage           19.50%    
ADS [Member]                
Intangible Assets [Line Items]                
Aggregate upfront payment (in Dollars)       $ 3,500